HOME >> BIOLOGY >> NEWS
Stem-cell research and reproductive cloning laws should be separate

The author of a Public Policy article in this week's issue of THE LANCET discusses recent failures of international organisations to establish clear policies with regard to stem-cell research and reproductive cloning. This will have implications for research scientists who will not be clear about the type of research programmes that could be publicly funded or that are legally permissible in the near future.

Carol A Tauer (Center for Bioethics, University of Minnesota, USA) outlines how late last year two international bodies were unable to resolve disagreements that involved bioethical issues. First, the United Nations General Assembly failed to pass a treaty on reproductive cloning because of insistence by some countries that the treaty include a ban on cloning for research. She argues that in view of the importance of enacting prohibition of reproductive cloning, the two issues should be separated and each argued on its own merits. Second, Dr Tauer discusses how the European Union (EU) failed to agree on conditions for funding stem-cell research because of the diversity of views and policies of the countries of the EU. Because a stalemate was reached, funding decisions in the next programme cycle will be made on an ad hoc basis.

Dr Tauer comments: "A country or group of countries can legitimately not fund certain controversial types of scientific or biomedical research. But a decision is preferable to a stalemate. Scientists who do not know what types of research proposals can be considered for funding are likely to shy away from a particular area of investigation. In this respect, the US rules, while restrictive, might have some advantages over the EU's lack of agreement on rules. If clear rules exist about what can and cannot be publicly funded then scientists can plan and seek private funding if necessary. The EU needs to break its stalemate and agree on funding policies, if not within the Sixth Framework Programme then at least by the time o
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
8-Jul-2004


Page: 1 2

Related biology news :

1. Stem-cell therapy could have benefits and risks for heart-attack PTs
2. Stem-cell defect underlies common genetic disorder
3. Leader in cancer treatment and prevention research honored
4. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
5. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
6. Belgian researchers explore revolutionary approach to angiogenesis
7. Award winning researchers reveal potential new role for Glivec
8. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
9. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
10. Gene chips research in cotton could lead to superior variety
11. Groundbreaking research could ignite new solutions to heat transfer in nano-devices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... NEW YORK (PRWEB) , ... December 03, 2018 ... ... with Cartessa Aesthetics , an emerging leader in the distribution and marketing ... has experienced rapid growth, projecting $20MM in sales for 2018. Cartessa’s success ...
(Date:12/5/2018)... ... 2018 , ... The new program allows 3rd ... innovative solutions for which high-speed imaging is a necessary albeit challenging component. , ... and instrumentation, allowing partner companies to dedicate their resources on their core strengths ...
(Date:11/27/2018)... ... 2018 , ... PulseEd™ uses researched technology, published in the Journal of ... flow to the penis. Regular and unimpeded blood flow to the blood vessels of ... function. The recorded results of SWT (sound wave therapy), indicated that almost 80% of ...
Breaking Biology News(10 mins):
(Date:11/11/2018)... ... , ... Triple W, an innovator of connected health devices, today announced that ... DFree ®, the first health tech wearable device for incontinence that monitors how full ... The announcement was made during CES Unveiled New York, an invite-only tech event bringing ...
(Date:11/9/2018)... ... November 08, 2018 , ... IC ... a machine-learning powered approach to increasing recovery rates by creating a comprehensive contact ... Collections (AIC) product developed by NLP Logix, a Jacksonville, Florida-based AI solutions company, ...
(Date:11/7/2018)... ... November 07, 2018 , ... ... a campaign to increase awareness of the adult tissue stem cell counting problem ... of November, the company is intensifying this effort with new educational publications and ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial Data ... data collection and management. TrialKit ™, an eClinical platform, has incorporated Apple’s ... quickly and easily sign in to the app via facial recognition or fingerprint ...
Breaking Biology Technology:
Cached News: